CD84/SLAMF5 Antibody (CD84.1.21)
Novus Biologicals, part of Bio-Techne | Catalog # NB100-65929
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunoprecipitation
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # CD84.1.21
Concentration
1.0 mg/ml
Product Specifications
Immunogen
Mouse pre-B cell line 300.19 transfected with CD84 cDNA
Localization
Type I membrane protein
Specificity
NB100-65929 recognizes the human CD84 cell surface antigen, a highly glycosylated cell surface antigen of 64-82kD. CD84 is predominantly expressed by B lymphocytes, monocytes and macrophages, although lower levels of expression have also been reported on T cells, granulocytes and platelets.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for CD84/SLAMF5 Antibody (CD84.1.21)
Flow Cytometry: CD84/SLAMF5 Antibody (CD84.1.21) - BSA Free [NB100-65929]
Flow Cytometry: CD84/SLAMF5 Antibody (CD84.1.21) [NB100-65929] - Staining of human peripheral blood monocytes with MOUSE ANTI HUMAN CD84.Applications for CD84/SLAMF5 Antibody (CD84.1.21)
Application
Recommended Usage
Flow Cytometry
1:100-1:200
Immunoprecipitation
1:10-1:500
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
PBS
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CD84/SLAMF5
Long Name
SLAM Family Member 5
Alternate Names
CD84, Ly-9B, SLAMF5
Entrez Gene IDs
8832 (Human)
Gene Symbol
CD84
UniProt
Additional CD84/SLAMF5 Products
Product Documents for CD84/SLAMF5 Antibody (CD84.1.21)
Product Specific Notices for CD84/SLAMF5 Antibody (CD84.1.21)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...